ƒz[ƒ€ > Œ¤‹†Žº‚Ì‚²Ð‰î > ƒXƒ^ƒbƒt‚Ì‚²Ð‰î

ƒXƒ^ƒbƒt‚Ì‚²Ð‰î

“Á”C‹³Žö@•Ä–ž ‹g˜a

•Ä–ž‹g˜a

yŠwˆÊz

  • ”ŽŽmiˆãŠwji‹ãB‘åŠwj

yŠw—ð‹y‚ѐE—ðz

1990”N3ŒŽ31“ú
@‹ãB‘åŠwˆãŠw•”ˆãŠw‰È‘²‹Æ

1990”N4ŒŽ1“ú
@ˆãˆõiŒ¤Cˆãji‹ãB‘åŠwˆãŠw•”•‘®•a‰@‘æ‚QŠO‰ÈA‹~‹}•”j

1991”N4ŒŽ1“ú
@ˆãˆõiŒ¤CˆãjiŒö—§ŠwZ‹¤Ï‘g‡‹ãB’†‰›•a‰@ŠO‰Èj

1992”N4ŒŽ1“ú
@‹ãB‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È”ŽŽm‰Û’öiŠO‰ÈŒnj“üŠw

1996”N3ŒŽ28“ú
@‹ãB‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰È”ŽŽm‰Û’öiŠO‰ÈŒnjC—¹

1996”N4ŒŽ1“ú
@ˆãˆõi‹ãB‘åŠwˆãŠw•”•‘®•a‰@‘æ‚QŠO‰Èj

1997”N11ŒŽ1“ú
@ƒŠƒT[ƒ`ƒAƒ\ƒVƒG[ƒgi˜A‡‰¤‘i‰p‘jƒƒ“ƒhƒ“‘åŠwƒCƒ“ƒyƒŠƒAƒ‹ƒJƒŒƒbƒWˆãŠw•”ˆâ“`ŽqŽ¡—ÊwuÀFDuncan Geddes‹³ŽöAEric Alton‹³Žöj

1999”N5ŒŽ1“ú
@•¶•”‹³Š¯@‹ãB‘åŠw•Žè ˆãŠw•”•‘®•a‰@i•a—•”j

2003”N6ŒŽ1“ú
@•¶•”‰ÈŠw‹³Š¯@‹ãB‘åŠwuŽt ˆãŠw•”•‘®•a‰@i•a—•”j

2003”N10ŒŽ1“ú
@•¶•”‰ÈŠw‹³Š¯@‹ãB‘åŠwuŽt •a‰@i•a—•”j

2004”N10ŒŽ1“ú
@‘—§‘åŠw–@l‹ãB‘åŠw•‹³ŽöiŠî‘bˆãŠwêUA•a—•a‘ÔŠw—̈æj

2006”N4ŒŽ1“ú
@‘—§‘åŠw–@lç—t‘åŠw‹³Žöi‹qˆõAˆâ“`ŽqŽ¡—Êñ•tuÀj

2006”N5ŒŽ01“ú
@iŒ“”Cj‘—§‘åŠw–@l‹ãB‘åŠw‹³Žöi“Á”CAÁ‰»Ší‘‡ŠO‰ÈŠw•tj

yŠw‰ïŠˆ“®“™z

  • American Heart/Stroke AssociationFƒtƒFƒ[iFAHAj
    - Silver Heart Grade- Premium Professional Member
    - Interdisciplinary Working Group Member on Atherosclerotic Peripheral Vascular Disease
  • “ú–{ˆâ“`ŽqŽ¡—Êw‰ï•]‹cˆõA“ú–{“®–¬d‰»Šw‰ï•]‹cˆõ
  • “ú–{–¬ŠÇŠw‰ï•]‹cˆõAŠO‰Èˆâ“`ŽqŽ¡—ÃŒ¤‹†‰ïí”CŠ²Ž–
  • American Society of Gene Therapy‰ïˆõA“ú–{ŠO‰ÈŠw‰ï‰ïˆõ
  • American Association of Immunologists‰ïˆõA“ú–{ŒŒŠÇŠO‰ÈŠw‰ï‰ïˆõ
  • “ú–{•a—Šw‰ï‰ïˆõiPathology International •ÒWˆÏˆõj@‘¼

ƒŠƒT[ƒ`ƒŒƒWƒfƒ“ƒg@‹g“c‹v”ü

Ž––±•â²@‘OŒ´ –¢‰›

–ß‚é

‚±‚̃y[ƒW‚̐擪‚Ö

Š³ŽÒ‚³‚܂ցbˆã—Ê֌WŽÒ‚ÌŠF—l‚Ö
dÇ‹•ŒŒŽˆ‚ɑ΂·‚錌ŠÇV¶ˆâ“`ŽqŽ¡—×Տ°Œ¤‹†‚ɂ‚¢‚ābŒŒŠÇˆâ“`ŽqŽ¡—Â̐isó‹µ‚ɂ‚¢‚ābŒ¤‹†Žº‚Ì‚²Ð‰î
‚¨‚µ‚点bƒŠƒ“ƒNWbƒTƒCƒgƒ}ƒbƒvb‚¨–â‚¢‡‚킹